| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/13/2008 | CN101242825A Use of L-carnitine and/or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 08/13/2008 | CN101242818A Use of a combination comprising L-carnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239093A Active component in albizia julibrissin with inhibiting angiogenesis function and preparation method and application thereof |
| 08/13/2008 | CN101239070A Eyedrops for curing eye affection and uses thereof |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410992 Ophthalmic compositions for treating ocular hypertension |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development |
| 08/12/2008 | US7410647 Vaccines |
| 08/12/2008 | US7410645 Moraxella (Branhamella) catarrhalis antigens |
| 08/12/2008 | CA2315721C Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 08/07/2008 | WO2008094958A1 Thiophene derivatives useful as medicaments for treating ocular hypertension |
| 08/07/2008 | WO2008094825A2 Compositions and methods for maintaining, strengthening, improving or promoting eye health |
| 08/07/2008 | WO2008094027A1 Use of suramin to prepare a drug for inhibiting retinal and corneal neovascularization |
| 08/07/2008 | WO2008093737A1 Amide derivative |
| 08/07/2008 | WO2008093691A1 Protective agent for retinal nerve or optic nerve |
| 08/07/2008 | WO2008093677A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 08/07/2008 | WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008054639A3 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 08/07/2008 | WO2008033449A3 Compounds for the treatment of angiogenesis |
| 08/07/2008 | US20080188562 Treating tinnitus using prodrugs of gabapentin and pregabalin |
| 08/07/2008 | US20080188441 Composition for Treating Inflammatory Diseases |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080187572 Administering compound which stabilizes cadherin |
| 08/07/2008 | US20080187526 Mixture comprising antioxidants for use in enhancing, preventing and treating hearing disorders |
| 08/07/2008 | CA2676291A1 Substituted gamma lactams as therapeutic agents |
| 08/07/2008 | CA2676163A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 08/07/2008 | CA2674913A1 Punctal plugs and methods of delivering therapeutic agents |
| 08/06/2008 | EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 08/06/2008 | EP1951279A2 Compstatin and analogs thereof for eye disorders |
| 08/06/2008 | EP1951236A2 Treatment of ophthalmic diseases with beta-amino alcohols |
| 08/06/2008 | EP1951229A2 Succinimide derivatives as ocular hypotensive agents |
| 08/06/2008 | EP1951071A2 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101234154A Composition Chinese medicine for treating scleritis |
| 08/06/2008 | CN101234136A Medicament for curing diabetes retina affection |
| 08/06/2008 | CN101234079A Azithromycin ophthalmic gel preparation composition and preparation and application thereof |
| 08/06/2008 | CN100408581C 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 08/06/2008 | CN100408100C Ophthalmic compositions containing galactomannan polymers and borate |
| 08/06/2008 | CN100408039C 止痒剂 Antipruritics |
| 08/06/2008 | CN100407948C A Chinese wolfberry cake and preparation process thereof |
| 08/05/2008 | US7407986 Administering a isothiocyanate, such as sulforaphane, or a glucosinolate; retinal degeneration, Alzheimer's Disease, and aging |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2332271C Selective cyclooxygenase-2 anti-inflammatory eye drops |
| 07/31/2008 | WO2008091860A1 Thiophene derivatives useful as ocular hypotensive agents |
| 07/31/2008 | WO2008091818A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | WO2008063639A3 Compositions and methods for preserving cells of the eye |
| 07/31/2008 | WO2008058274A3 Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2007141533A3 Fkbp-l and uses thereof |
| 07/31/2008 | US20080183123 nucleic acid composition for injection; ciliary body tissue(s) or cells and/or to the extra-ocular muscle tissue or cells; antiproliferative, antiinflammatory, antiischemic agent; neurodegenerative diseases; ocular disease, vision deffects |
| 07/31/2008 | US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride |
| 07/31/2008 | US20080182906 Therapy for diabetic retinopathy |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182854 4-Amino-5-Cyanopyrimidine Derivatives |
| 07/31/2008 | US20080182811 Activating a metabotropic glutamate receptor by administering one or more kinds of amino acids selected from amino acids other than glutamic acid; use in treating neurological diseases, cardiovascular diseases, surgical diseases, neurosurgical diseases, thoracic surgical diseases, orthopedic diseases |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182320 Two-step immunization procedure against chlamydia infection |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080181972 alpha -lipoic acid, ascorbic acid, and alpha -tocopherol, optionally one or more other antioxidants, beneficial minerals, and/or nutritional or dietary materials; diabetic retinopathy or diabetic macular edema, cataract, glaucoma, ocular inflammation |
| 07/31/2008 | US20080181960 Solid dispersion of completely amorphous carotenoids; polyvinylpyrrolidone, hydroxypropylcellulose hydroxypropylmethylcellulose solubility-enhancing polymers;spray dried powder increased bulk density; substantially free of lipids and oils |
| 07/31/2008 | US20080181931 Antimicrobial medical devices including silver nanoparticles |
| 07/31/2008 | US20080181929 biodegradable polymer and a therapeutic agent for the treatment of retinal tissue; active substance is at least one member selected from the group consisting of dexamethasone and fluocinolone |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/31/2008 | US20080181900 Vascular Endothelial Cell Growth Factor Antagonists |
| 07/31/2008 | US20080181893 Therapeutic methods for treating vascular eye disorders with DII4 antagonists |
| 07/31/2008 | US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup |
| 07/31/2008 | US20080181867 preparing a pre-concentrate by emulsifying an oil phase castor oil with water and a water soluble pharmaceutically active substance cyclosporine A, then dilute to desired concentration; eye drops for eye disorders; less time and low energy consuming, no negative impact on the chemical stability |
| 07/31/2008 | DE202006020318U1 Therapeutische Zusammensetzungen und ihre Verwendung Therapeutic compositions and their use |
| 07/31/2008 | CA2676252A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | CA2675981A1 Thiophene derivatives useful as ocular hypotensive agents |
| 07/30/2008 | EP1950302A2 Streptococcus antigens |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1948596A2 Soft anticholinergic esters |
| 07/30/2008 | EP1948212A2 Treatment of dry eye |
| 07/30/2008 | EP1948145A2 Protection of oxidizable agents |
| 07/30/2008 | EP1948131A2 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 07/30/2008 | EP1418881B1 Synergistic antimicrobial ophthalmic preparations containing chlorite and hydrogen peroxide |
| 07/30/2008 | CN101233110A Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 07/30/2008 | CN101232902A Noninvasive drug delivery system to posterior part tissue of eye by using solid composition |
| 07/30/2008 | CN101232882A Percutaneously absorbable ophthalmic preparation |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229365A Applications of nerve growth factor(NGF) on preparing medicine for treating pathological myopia |
| 07/30/2008 | CN101229325A Rhizoma gastrodiae chewable tablet and preparing method thereof |
| 07/30/2008 | CN101229287A Polynary lycopene preventing and treating eye disease capsule and preparing method thereof |